September 10, 2025 – Page 2 – Start Medical Product Development

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity

September 10, 2025

NAPLES, Fla., Sept. 10, 2025 /PRNewswire/ — Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 50 mg per vial, Single-Dose Vials.

Abbott reports first commercial Tendyne mitral valve implant in the U.S.

September 10, 2025

An Abbott (NYSE: ABT)+
official announced on social media that doctors completed the first commercial implant of Tendyne in the U.S.

Levita Magnetics reports first AI-guided autonomous gall bladder surgery with MARS system

September 10, 2025

Levita Magnetics announced today that surgeons used its MARS platform to perform the world’s first gall bladder surgery featuring an autonomous surgical camera.

Blog